Insulet
(Nasdaq: PODD)
stock is down on second-quarter results that came in mixed compared to the consensus forecast.
Our sibling site, Drug Delivery Business News, has the latest today on the company’s second-quarter earnings report, which Insulet released yesterday evening.
Shares of PODD were down more than 7% to $184.56 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly.
Adjusted to exclude one-time items, the automated insulin delivery technology developer’s earnings per share came in at 55¢. That fell just shy of expectations on Wall Street. However, the company posted a sales beat compared to the experts’ projections.
